CopyMark Law Group
4.9/5
Drawing for INVITRIA

USPTO serial 88131095

INVITRIA

Reviewed by CopyMark Law Group

Reg. 5860456Status 702Registered
Filing date
Status date
Registration date
Sep 17, 2019
Examiner
MCCARTHY, BRIDGET ANN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with INVITRIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Crissa A. Cook

Crissa A. Cook HOVEY WILLIAMS LLP10801 Mastin Blvd., Suite 1000OVERLAND PARK, KS 66210-1697United States

Goods and services

ClassDescriptionStatusFirst use
001Cell culture media and cell culture media components for scientific and research use, namely for development of biochemicals, cultured foods, life science research and development and tissue preservation; blood serum substitutes and serum proteins using non-animal manufacturing systems for use in the manufacture of pharmaceutical and veterinary preparations; blood product replacements and non-animal derived recombinant proteins for scientific and research use; Excipients for use in the manufacture of pharmaceutical preparationsACTIVEApr 17, 2007
005Cell culture media and cell culture media components for medical or veterinary use, namely, for development of biopharmaceuticals, vaccines, gene therapies, cell therapies, and medical devices; pharmaceutical excipients, diluents for medical use, drug delivery agents in the form of diluents and coatings for tablets, capsules, particles, powders, and granules that facilitate the delivery of pharmaceutical and veterinary preparations and drug delivery systems; blood product replacements and non-animal derived recombinant proteins for medical or veterinary useACTIVEApr 17, 2007
042Providing design and development of cell culture media and media components; research and development for others in the field of non-animal derived cell culture media and media componentsACTIVEApr 17, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 10, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 3, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 25, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Sep 17, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 17, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 12, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 29, 2019ALIEASSIGNED TO LIE—
May 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2018DOCKASSIGNED TO EXAMINER—
Oct 3, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance